
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Increased Seroprevalence and Improved Antibody Responses Following Third Primary SARS-CoV-2 Immunisation: An Update From the COV-AD Study
Adrian M. Shields, Sian Faustini, Harriet J. Hill, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Adrian M. Shields, Sian Faustini, Harriet J. Hill, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Showing 22 citing articles:
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
Adrian M. Shields, Susan Tadros, Adam Al‐Hakim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Adrian M. Shields, Susan Tadros, Adam Al‐Hakim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1104-1117
Open Access | Times Cited: 12
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 6, pp. 1104-1117
Open Access | Times Cited: 12
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Leanne P. M. van Leeuwen, Marloes Grobben, Corine H. GeurtsvanKessel, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
COVID-19 Vaccination Responses with Different Vaccine Platforms in Patients with Inborn Errors of Immunity
Lorenzo Erra, Ignacio Uriarte, Ana Colado, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 2, pp. 271-285
Open Access | Times Cited: 18
Lorenzo Erra, Ignacio Uriarte, Ana Colado, et al.
Journal of Clinical Immunology (2022) Vol. 43, Iss. 2, pp. 271-285
Open Access | Times Cited: 18
Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022
Rebecca Amati, Anja Frei, Marco Kaufmann, et al.
Eurosurveillance (2022) Vol. 27, Iss. 31
Open Access | Times Cited: 16
Rebecca Amati, Anja Frei, Marco Kaufmann, et al.
Eurosurveillance (2022) Vol. 27, Iss. 31
Open Access | Times Cited: 16
Cohort profile:Stop the Spread Ottawa (SSO)—a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 15
Erin Collins, Yannick Galipeau, Corey Arnold, et al.
BMJ Open (2022) Vol. 12, Iss. 9, pp. e062187-e062187
Open Access | Times Cited: 15
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Varying Cellular Immune Response against SARS-CoV-2 after the Booster Vaccination: A Cohort Study from Fukushima Vaccination Community Survey, Japan
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 920-920
Open Access | Times Cited: 7
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 920-920
Open Access | Times Cited: 7
Long-Term Immunological Memory of SARS-CoV-2 Is Present in Patients with Primary Antibody Deficiencies for up to a Year after Vaccination
Zane Lucāne, Baiba Šlisere, Lota Ozola, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 354-354
Open Access | Times Cited: 6
Zane Lucāne, Baiba Šlisere, Lota Ozola, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 354-354
Open Access | Times Cited: 6
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access | Times Cited: 1
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access | Times Cited: 1
Functionally impaired antibody response to BNT162b2 booster vaccination in CVID IgG responders
Kai M. T. Sauerwein, Christoph B. Geier, R Stemberger, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 922-925
Open Access | Times Cited: 6
Kai M. T. Sauerwein, Christoph B. Geier, R Stemberger, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 922-925
Open Access | Times Cited: 6
Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies
Adrian M. Shields, Sian Faustini, Siobhan K. Young, et al.
eJHaem (2023) Vol. 4, Iss. 2, pp. 339-349
Open Access | Times Cited: 3
Adrian M. Shields, Sian Faustini, Siobhan K. Young, et al.
eJHaem (2023) Vol. 4, Iss. 2, pp. 339-349
Open Access | Times Cited: 3
Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults
Panagiotis Ferentinos, D Snape, Fiona N. Manderson Koivula, et al.
Journal of Immunological Methods (2023) Vol. 518, pp. 113492-113492
Open Access | Times Cited: 2
Panagiotis Ferentinos, D Snape, Fiona N. Manderson Koivula, et al.
Journal of Immunological Methods (2023) Vol. 518, pp. 113492-113492
Open Access | Times Cited: 2
The Scope and Impact of Viral Infections in Common Variable Immunodeficiency (CVID) and CVID-like Disorders: A Literature Review
Adam Al‐Hakim, Mark Kačar, Sinisa Savic
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1717-1717
Open Access
Adam Al‐Hakim, Mark Kačar, Sinisa Savic
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1717-1717
Open Access
An Overview of the Immune Response to COVID-19 Vaccination and Strategies to Boost SARS-CoV-2 Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
(2024)
Open Access
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
(2024)
Open Access
Antibody responses to inactivated and/or mRNA SARS-CoV-2 vaccination in patients with inborn errors of immunity
Esra Karabıber
The Annals of Clinical and Analytical Medicine (2024) Vol. 15, Iss. 06
Open Access
Esra Karabıber
The Annals of Clinical and Analytical Medicine (2024) Vol. 15, Iss. 06
Open Access
Adaptive Cellular Responses following SARS-CoV-2 Vaccination in Primary Antibody Deficiency Patients
Sudhir Gupta, Houfen Su, Sudhanshu Agrawal, et al.
Pathogens (2024) Vol. 13, Iss. 6, pp. 514-514
Open Access
Sudhir Gupta, Houfen Su, Sudhanshu Agrawal, et al.
Pathogens (2024) Vol. 13, Iss. 6, pp. 514-514
Open Access
Changing Patterns of SARS-CoV-2 Seroprevalence: A Snapshot among the General Population in Kuwait
Wadha Alfouzan, Haya Altawalah, Ahmad Al‐Sarraf, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 336-336
Open Access | Times Cited: 1
Wadha Alfouzan, Haya Altawalah, Ahmad Al‐Sarraf, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 336-336
Open Access | Times Cited: 1
Safety and Immunogenicity of 3 Doses of BNT162b2 and CoronaVac in Children and Adults with Inborn Errors of Immunity
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 2
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 2
Correlation between Clinical and Immunological Variables and Humoral Response to SARS-CoV-2 Vaccination in Adult Patients with Antibody Deficiency Disorders
Carmen Bracke, Cristina Miranda, Sandra González, et al.
Pathogens (2022) Vol. 11, Iss. 11, pp. 1364-1364
Open Access | Times Cited: 1
Carmen Bracke, Cristina Miranda, Sandra González, et al.
Pathogens (2022) Vol. 11, Iss. 11, pp. 1364-1364
Open Access | Times Cited: 1
Detection of specific RBD+ IgG+ memory B cells by flow cytometry in healthcare workers and patients with inborn errors of immunity after BNT162b2 m RNA COVID-19 vaccination
Lucía del Pino Molina, Luz Yadira Bravo‐Gallego, Pilar Nozal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
Lucía del Pino Molina, Luz Yadira Bravo‐Gallego, Pilar Nozal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access
What Proportion of Population has achieved Cellular Immunity against SARS-CoV-2 after Booster Vaccination: A Cross-sectional Study
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Research Square (Research Square) (2022)
Open Access
Yuta Tani, Morihito Takita, Yurie Kobashi, et al.
Research Square (Research Square) (2022)
Open Access